Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 has been added to the Record History, and v3.3.1 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T10:51:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Record History shows a new version entry (v3.3.1) added and removal of v3.2.0, indicating routine history updates rather than substantive changes to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:59:29.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Deleted a site-wide notice about government funding and operating status. The change does not alter the study details or history records shown on the page.
    Difference
    0.8%
    Check dated 2025-11-17T06:18:01.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The version history shows recruitment status updates on 2022-01-25, 2022-05-18, and 2025-08-14, and a study status update on 2025-02-28. No new sections were added or removed; only status fields were updated.
    Difference
    0.1%
    Check dated 2025-11-03T00:49:19.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    - Replaced version tag from v3.1.0 to v3.2.0 and added a prominent notice about government funding impact and operating status with references to NIH Clinical Center and official sources.
    Difference
    13%
    Check dated 2025-10-05T07:14:05.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the site/page version from v3.0.2 to v3.1.0, indicating a newer release. No other substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T02:54:02.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.